Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06929442 · ClinicalTrials.gov registry record · NA

A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

A NA study of Anxiety Disorders and Mood Disorders, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
192
Enrollment target
1
Study location

NCT06929442: Recruiting NA study of Anxiety Disorders and Mood Disorders, sponsored by Massachusetts General Hospital.

NCT06929442 is a NA study of Anxiety Disorders and Mood Disorders that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 192 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06929442, a NA study of Anxiety Disorders and Mood Disorders, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
192 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.

Primary Outcome

The Peters Delusions Inventory (PDI) is a brief 21-item survey using non-stigmatizing and non-clinical language that obtains ratings of common delusional experiences (e.g. paranoia, grandiosity, ideas of reference) and perceptual aberrations (e.g. experiences of being controlled; thought insertion, withdrawal, and echoing), i.e., psychotic experiences. The PDI also measures conviction, preoccupation, and distress related to these experiences. This scale is scored from 0-21, with higher scores in

Interventions

  • BEHAVIORAL Resilience Training (RT)
  • BEHAVIORAL Life Skills Training (LST)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2025-02-10
Est. Completion 2029-06
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06929442 shows while recruiting

NCT06929442 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (83% lower).

The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Resilience Training (RT) is the first listed.

NCT06929442 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06929442 about?

NCT06929442 is a clinical study titled "A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences". This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.

What is the current status of trial NCT06929442?

This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2025-02-10. Estimated completion is 2029-06.

What conditions does trial NCT06929442 study?

This clinical trial studies the following conditions: Anxiety Disorders, Mood Disorders, Psychotic Disorders.

What interventions are being tested in trial NCT06929442?

The interventions under investigation include: Resilience Training (RT) (BEHAVIORAL), Life Skills Training (LST) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06929442?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06929442 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06929442's enrollment target sits among peer trials

192 27th of 84 higher than 58 of 84 other Anxiety Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

  • NCT02535702 · 192 participants · NA

    Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

  • NCT03622359 · 192 participants · NA

    Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06929442, the US trial registry maintained by the National Library of Medicine. NCT06929442 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.